Filing Details
- Accession Number:
- 0000899140-10-000071
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2010-01-27 12:00:00
- Reporting Period:
- 2010-01-26
- Filing Date:
- 2010-01-27
- Accepted Time:
- 2010-01-27 16:45:26
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1087432 | Intermune Inc | ITMN | Pharmaceutical Preparations (2834) | 943296648 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1215242 | S Jonathan Leff | C/O Warburg Pincus &Amp; Co. 450 Lexington Avenue New York NY 10017 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock, Par Value $0.001 Per Share ("Common Stock") | Acquisiton | 2010-01-26 | 2,127,660 | $14.10 | 9,485,209 | No | 4 | P | Indirect | See footnotes |
| Common Stock | Acquisiton | 2010-01-26 | 40,000 | $4.50 | 9,525,209 | No | 4 | M | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Indirect | See footnotes |
| No | 4 | M | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2010-01-26 | 30,000 | $0.00 | 30,000 | $4.50 |
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2010-01-26 | 10,000 | $0.00 | 10,000 | $4.50 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2000-01-31 | 2010-01-31 | No | 4 | M | Direct |
| 0 | 2000-02-08 | 2010-02-08 | No | 4 | M | Direct |
Footnotes
- See Note 1 on Exhibit 99.1 attached hereto.
- See Note 2 on Exhibit 99.1 attached hereto.
- See Note 3 on Exhibit 99.1 attached hereto.
- See Note 4 on Exhibit 99.1 attached hereto.
Billionaire Hedge Funds
